W2 Blood Pressure Control (Pharmacotherapeutics) Flashcards

AKA Antihypertensive Drugs 1

1
Q

What is the pathway for antihypertensives for an individual with hypertension with type 2 diabetes?

A
  1. ACEi or ARB
    2.ACEi or ARB +++ CCB or thiazide-like diuretic
  2. ACEI or ARB + CCB + thiazide-like diuretic
  3. Confirm resistant hypertension: confirm elevated BP with ABPM or HBPM, check for postural hypertension and discuss adherence
  4. Consider seeking expert advice or adding a:
    - Low-dose spironolactone if blood potassium level is <4.5mmol/l
    - Alpha-blocker or beta-blocker if blood potassium level >4.5 mmol/l

See expert advice is BP is uncontrolled on optimal tolerated doses of 4 drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the pathway for antihypertensives for an individual with hypertension without type 2 diabetes/ Age 55 or over or Black-African-Caribbean family origin (any age)?

A
  1. CCB
  2. CCB + ACEi OR ARB or thiazide-like diuretic
  3. CCB + ACEi OR ARB + thiazide-like diuretic
  4. Consider seeking expert advice or adding a:
    - Low-dose spironolactone if blood potassium level is <4.5mmol/l
    - Alpha-blocker or beta-blocker if blood potassium level >4.5 mmol/l

See expert advice is BP is uncontrolled on optimal tolerated doses of 4 drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Monitoring treatment:
Measure standing and sitting BP in people with..?

A

Measure standing and sitting BP with
1. Type 2 diabetes
2. Symptoms of postural hypertension
3. Aged 80 and over

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a pro-drug?

A

A prodrug is a compound that has little or no activity on a desired pharmacological target but is converted to an active, or more active, entity by an endogenous metabolic reaction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Angiotensin ll?
At1 receptor activation ( Gq coupled receptor) leads to what…?

A

A peptide hormone, that acts at AT1
receptors, stimulating both vasoconstriction ( inc peripheral resistance) and aldosterone release ( Inc CO by inc blood vol)
=This leads to increasing blood pressure which we want to prevent

Vascular smooth muscle: vasoconstriction
Adrenal Cortex: aldosterone release
Adrenergic innervations: adrenaline release and inhibit reuptake (synergistic effect on heart and blood vessels)
Pituitary gland- Antidiuretic hormone (ADH) release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ACEi:
(Angiotensin-converting enzyme inhibitors)
What is ACE? (structure)

Where is is localised?

A
  • ACE is a zinc-containing dipeptidyl
    carboxypeptidase enzyme (150 to 180 kDa,
    also known as kininase II)
  • ACE is primarily localised on the luminal side of the vascular endothelium. The lung, which has a vast surface area of vascular endothelium, is rich in ACE. It is also present in other organs including the kidney, heart, brain, and striated muscle skin, as it is a part of local RAASs
  • ACE cleaves the terminal histidyl-leucine from angiotensin I (decapeptide) to form the octapeptide angiotensin II
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the mechanisms of ACE inhibitors?

A
  1. Arterial and Venous vasodilation (no vasoconstriction)
    * Reduction in arterial & venous pressure
    * Reduction in ventricular preload & afterload
  2. Decrease blood volume (no aldosterone release)
    * Natriuresis
    * Diuresis
  3. Downregulation of sympathetic activity
  4. Suppression of hypertrophy (cardiac and vascular

ACE is inhibited so Angiotensin ll is unable to be converted into Angiotensin ll to act at AT1 receptors so vasoconstriction and aldosterone release does not occur so a dec in peripheral resistance and dec in cardiac output so leads to blood pressure reduction

ACE inhibitors lower blood pressure by reducing the vasoconstriction induced by angiotensin II, thereby decreasing peripheral resistance.
Consequently, the lower Ang II level reduces the sodium and water reabsorption and cardiac output.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are examples of ACE inhibitors?
( name ending…?)

A

‘pril’ drugs
*Captopril (first marketed, not a pro-drug, shorter half-life)
*Enalapril (more recent, longer duration of action)
*Fosinopril
*Imidapril
*Lisinopril (not a pro-drug)
*Perindopril
*Quinapril
*Ramipril (More recent, longer duration of action)
*Trandolapril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pharmacokinetics of (ACE) inhibitors
What are the ADME processes of ACE inhibitors?

A

A: 40-66% bioavailable depends on the
drug
D: Binds to tissue and plasma protein
M: Metabolised in the liver
E: Eliminated through the kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the ADME processes of Captopril?

A

Captopril= absorbed and eliminated rapidly (not a prodrug)

A: 40-66% bioavailable depends on the
drug
D: Binds to tissue and plasma protein
M: Metabolised in the liver
E: Eliminated through the kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the ADME processes of Enalapril?

A

Enalapril, like most of the later ACE inhibitors, is an inactive pro-drug that requires hydrolysis during or active absorption to generate the active acid form, enalaprilat.

A: 40-66% bioavailable depends on the
drug
D: Binds to tissue and plasma protein
M: Metabolised in the liver
E: Eliminated through the kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the ADME processes of Lisinopril?

A

Lisinopril is an analogue of enalapril and is itself active. Lisinopril is not metabolized and is excreted as an unchanged drug. Lisinopril is entirely eliminated exclusively in the urine.

A: 40-66% bioavailable depends on the
drug
D: Binds to tissue and plasma protein
M: Metabolised in the liver
E: Eliminated through the kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the most common side effect of ACEi and why?

A

Dry, irritant cough in about 15% (10% of men and 20% of women) is attributable to
the accumulation of bradykinin.
- ACE metabolises bradykinin but is inhibited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Bradykinin?

A

Bradykinin is a potent vasodilator peptide that exerts its vasodilatory action through stimulation of specific endothelial B2 receptors. It causes arterioles to dilate (enlarge) via the release of prostacyclin, nitric oxide, and endothelium-derived hyperpolarizing factor and makes veins constrict.

ACE inhibitors block the breakdown of bradykinin and increase bradykinin levels, which can contribute to the vasodilator action.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Accumulation Bradykinin?

A
  • Accumulation bradykinin induces sensitization of airway sensory nerves via rapidly adapting stretch receptors and C-fiber receptors that release neurokinin A and substance P.
  • This causes airway smooth muscle to constrict leading to bronchoconstriction and persistent dry cough. (most common adverse effect, 10-20% of patients)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is bradycardia?

A

A low heartbeat
SE of a medicine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Adverse effects of ACEi:
Most common?
Rare (but potentially detrimental)

A

Most common:
Dry, irritant cough in about 4-35% is attributable to the accumulation of bradykinin.

Rare (but potentially detrimental)
* Hyperkalaemia (due to potassium retention is mediated by the reduction of aldosterone)
* Taste disturbance (ACE inhibitors affect the Zinc of the ACE protein in the salivary gland cells)
* Hypotension (due to renin-angiotensin system)
* Renal impairment (vicious cycle)
* Angioedema (kinin potentiation); Skin rashes, Urticaria

18
Q

What are the clinical considerations of ‘prils’? (3)
(General scheme SE)

A
  1. Cough is not dose-dependent and is a class effect (dose titration isn’t helpful)
  2. Hypotension: combine with low-dose diuretics.
  3. Dehydration (diarrhoea, vomiting, postural hypotension and acute kidney disease):
    suspend temporarily.
19
Q

Renal risk assessment

A
  • ACE inhibitors are beneficial for patients with chronic renal failure and hypertension
  • Monitor serum creatinine and potassium (shouldn’t be raised 20% more than the reference range)
  • Periodically assess renal structure and function
  • Discontinue ACE inhibitors for patients with bilateral renal artery stenosis
20
Q

What is angiotensin ll?
Where does it act?

A

Angiotensin II is a peptide hormone, that acts at AT1receptor

21
Q

ACE inhibitors are either not prescribed or avoided as the first-line option for which categories of patients?(3)

A
  • 55 or above years (natural ageing of renal function)
  • Caribbean or black African ethnic origin (less response to renin-dependent BP regulation)
  • Pregnant and breastfeeding women
22
Q

How do ARBs work?

A
  • ARBs are receptor antagonists that
    block type 1 angiotensin II (AT1) receptors on blood vessels and other tissues such as the heart.
  • AT1 receptors are coupled to the Gq-protein and IP3 signal transduction pathway that stimulates vascular smooth muscle contraction
  • The outcome/effect is similar to ACEi’s
    Angiotensin II
23
Q

List some examples of ARB’s

A

‘sartan’ drugs
Candesartan
(prodrug)
irbesartan
Losartan (prodrug)
valsartan
olmesartan

24
Q

What are the ADME Properties of ARBs?

A

A: Readily absorbed, 20-66% bioavailability
depending on the drug
D: Binds to plasma protein (>90%)
M: Metabolised in the liver (CYP450 2C9)
E: Eliminated through the kidney

25
Q

Do ARBs have a lot of SE?
What are the adverse effects of ARBs? (8)

A

ARBs have a relatively low incidence of side effects and are well-tolerated

(potentially detrimental)
* Hyperkalaemia (due to potassium retention is mediated by the reduction of aldosterone)
* Renal impairment (vicious cycle)
* Headache, fainting, dizziness, fatigue, respiratory symptoms
* Vomiting and Diarrhoea (D&V)
* Back pain, leg swelling, allergic reactions
* Liver failure, kidney failure, angioedema, or tissue swelling
* Lower white blood cell (WBC) counts
* Irregular heartbeat caused by high blood potassium levels

26
Q

When are ARBs contraindicated? (2)

A
  1. In pregnancy
    Also…
  2. Patients with bilateral renal artery stenosis*
    may experience renal failure if ARBs are
    administered.
    =Monitor renal risks- eGFR, creatinine levels

*Narrowing of both renal arteries

27
Q

What is renin?
How do renin inhibitors work?
What is an example?

A

Renin is a proteolytic enzyme (hormone) that catalyses the conversion of angiotensinogen to angiotensin

Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation

Aliskiren- a selective nonpeptide renin inhibitor with antihypertensive activity. It selectively binds to the S3 sub-pocket of renin

28
Q

What do calcium channel blockers work against to inhibit? (in the name)

A

The L-type calcium channels located on the vascular smooth muscle, cardiac myocytes, and cardiac nodal tissue (SA and AV nodes) regulate the calcium influx and stimulate smooth muscle and cardiac myocyte contraction.
(Recollect cardiac and smooth muscle contraction)

29
Q

What are some examples of CCBs?

A

Dihydropyridines
*amlodipine
*felodipine
*isradipine
*nicardipine
*nifedipine
*nimodipine
*nitrendipine

Non-dihydropyridines:
* Verapamil (phenylalkylamine)
* Diltiazem (Benzothiazepine)

30
Q

What effects do CCBs have?
- Vascular effect
- Cardiac effect

A
  • Vascular effect
    -vascular smooth muscle relaxation (vasodilation)
  • Cardiac effect
    -decreased myocardial force generation (negative inotropy),
    -decreased heart rate (negative chronotropy),
    -decreased conduction velocity within the heart (negative dromotropy)
31
Q

What are the properties of Dihydropyridine CCBs?
What are the Side effects & Contraindications?

A

Highly vascular selective and reduce systemic vascular resistance and arterial
pressure.

Side effects & contra-indications
* flushing
* headache
* excessive hypotension
* oedema (ankle swelling)*
* reflex tachycardia (Baroreceptor reflex-
refresh neural regulation of BP)

  • why?- CCB dilates arteries
  • Veins remain constricted
  • Capillary overload forces fluid into surrounding tissue
32
Q

What are some examples of non-dihydropyridines (CCBs)
What are the Side effects? (3)
Contra-indications? (2)

A

Cardiac specific
Verapamil is relatively selective for the myocardium and is less effective as a systemic vasodilator drug.
But- Diltiazem is intermediate between verapamil and dihydropyridines in its selectivity for vascular calcium channels

  • Bradycardia (excessive)
  • AV node block (impaired electrical conduction)
  • Contractility (Cardiac depression)

Heart failure, Severe Hypotension,

33
Q

What are the properties of thiazide/thiazide-like diuretics?
What is the name ending for this class?
What are some examples?

A
  • Moderately powerful diuretics
  • Cause 5% of filtered Na+ to be excreted
    Block Na+ / Cl- symporter of early DCT
  • Inhibit active Na+ reabsorption and accompanying Cl- transport (promote natriuresis and diuresis

‘ide’ & ‘one’ drugs
Bendroflumethiazide
Thiazide related- chlortalidone, indapamide
(metolazone)

34
Q

What are the side effects of thiazides and thiazide-like diuretics?

A

*Hypokalaemia (Potassium loss due to increased sodium delivery to distal tubule)
*Metabolic alkalosis (increased hydrogen ion loss in the urine)
*Dehydration (hypovolemia),
*Leading to hypotension
*Hyponatremia

35
Q

What is the major clinical problem that can arise from thiazide and thiazide-like diuretics?
What are the clinical considerations?

A
  • more negative membrane potential
  • cardiac arrhythmias
  • reduce the activity of Na+/K+
    ATPase pump

o Potassium supplements
o Potassium-sparing diuretics
o ACEi’s (as they cause hyperkalaemia

36
Q

What are some examples of Potassium-sparing diuretics?

A
  1. Aldosterone receptor antagonists (spironolactone, eplerenone)
    – Antagonize aldosterone (mineralocorticoid) receptors
    – Prevent insertion of pumps (Na+/K+ ATPase) and channels (ENaC) in late
    DCT and CD.
  2. Na+ channel blockers (Amiloride and triamterene)
    * Block apical ENaC in late DCT and CD
    * Na+ no longer retained at expense of K+
37
Q

Differences between dihydropyridine and nondihydropyridine

A

Dihydropyridine (DHP) CCBs tend to be more potent vasodilators than non dihydropyridine (non-DHP) agents, whereas the latter have more marked negative inotropic effects.

38
Q

How do beta-blockers work?

A

Target beta B-1 adrenergic receptor
- Inc HR
- Inc cardiac muscle’s force of contraction
e.g. Propanalol= anti-hypertensive

39
Q

What cardiac effects do these drugs have?
*atenolol
*bisoprolol
*carvedilol
*labetalol
*metoprolol

A

Decrease contractility
Decrease relaxation rate
Decrease heart rate
Decrease conduction velocity

40
Q

What vascular effect does propanalol have?

A

Smooth muscle contraction
(mild vasoconstriction)

41
Q

What are some other classes of drugs used in Hypertension?

A

Diuretics:
- loop diuretics (Inhibits sodium reabsorption in the loop of Henle; eg
furosemide)

Vasodilators:
- alpha-adrenoceptor antagonists (alpha-blockers; block adrenaline binding vascular
smooth muscle and lead to vasodilation; prazosin, doxazosin)
- direct-acting arterial dilators (unknown MOA, hydralazine)
- nitrodilators (NO-induced arterial and venous dilation, isosorbide, nitro-glycerine,
sodium nitroprusside)
- potassium-channel openers (activate (open) ATP-sensitive K+-channels in
vascular smooth muscle, hyperpolarizes the smooth muscle, which closes voltage-
gated calcium channels and decreases intracellular calcium; minoxidil)

Centrally acting sympatholytics -alpha 2 adrenoceptor inhibition in the CNS; e.g
clonidine, guanfacine, methyldopa)